Clinical Trial Update: A Study of Chemoradiation Associated with Nimotuzumab As the Treatment of Locally Advanced Esophageal Cancer [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 study evaluating nimotuzumab in combination with chemoradiation for locally advanced esophageal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma
• Esophageal Cancer

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Esophageal Cancer, Adenocarcinoma | Phase 2, Phase 3 | Status: COMPLETED